| Non-fatality n = 123 (%) | Fatality n = 57 (%) | p value | OR | 95% CI |
---|---|---|---|---|---|
Sex (Male/female) | 76/45 | 32/25 | 0.435 | Â | Â |
Mean age at onset | 50.89 ± 18.8 | 56.49 ± 17.16 | 0.058 |  |  |
Mean GCS on presentation | 13.65 ± 12.35 | 11.12 ± 4.30 | <0.0001 |  |  |
Underlying diseases | Â | Â | Â | Â | Â |
Diabetes mellitus | 20 (16.2) | 14 (24.6) | 0.186 | 1.677 | 0.776-3.622 |
Pulmonary TB | 8 (6.5) | 4 (7.0) | 1 | 1.085 | 0.313-3.762 |
Systemic lupus erythematosus | 7 (5.7) | 1 (1.8) | 0.439 | 0.296 | 0.036-2.464 |
Liver cirrhosis | 4 (3.3) | 9 (15.8) | 0.004 | 5.578 | 1.639-18.98 |
Chronic alcoholism | 1 (0.8) | 2 (3.5) | 0.236 | 4.436 | 0.394-49.964 |
Autoimmune diseases | 2 (1.6) | 3 (5.2) | 0.328 | 3.361 | 0.546-20.697 |
Hematologic diseases | 6 (4.9) | 2 (3.5) | 1 | 0.709 | 0.139-3.627 |
Malignance | 6 (4.9) | 5 (8.8) | 0.31 | 1.875 | 0.548-6.421 |
Iatrogenic Cushing syndrome | 5 (4.0) | 8 (14.0) | 0.016 | 3.853 | 1.201-12.364 |
Clinical features | Â | Â | Â | Â | Â |
Fever/chills | 68 (55.3) | 42 (73.7) | 0.018 | 2.265 | 1.138-4.508 |
Headache | 60 (48.8) | 27 (47.4) | 0.86 | 0.945 | 0.504-1.772 |
Disturbed consciousness | 44 (35.8) | 33 (57.9) | 0.005 | 2.469 | 1.299-4.692 |
Visual disturbance | 19 (15.4) | 7 (12.3) | 0.574 | 0.766 | 0.302-1.942 |
Hearing impairment | 4 (3.3) | 2 (3.5) | 1 | 1.082 | 0.192-6.085 |
Seizure | 13 (10.6) | 15 (26.3) | 0.007 | 3.022 | 1.326-6.885 |
Neuro-imaging findings at presentation | Â | Â | Â | Â | Â |
Hydrocephalus | 59 (48.0) | 31 (54.4) | 0.423 | 1.293 | 0.689-2.428 |
Cerebral infarction | 12 (9.8) | 6 (10.5) | 0.873 | 1.088 | 0.387-3.062 |
Gyral enhancement | 13 (10.6) | 6 (10.5) | 0.996 | 0.995 | 0.358-2.768 |
Basal cistern effacement | 5 (4.0) | 6 (10.5) | 0.092 | 2.776 | 0.81-9.513 |
Pseudo-cyst | 8 (6.5) | 3 (5.3) | 1 | 0.799 | 0.204-3.129 |
Dilated Virchow-Robin space | 9 (7.3) | 4 (7.0) | 1 | 0.956 | 0.282-3.245 |
Mass lesions | 6 (4.9) | 4 (7.0) | 0.728 | 1.472 | 0.399-5.433 |
Peripheral blood testing | Â | Â | Â | Â | Â |
Leukocytosis | 28 (22.8) | 17 (29.8) | 0.309 | 1.442 | 0.711-2.924 |
Leucopenia | 2 (1.6) | 0 | 1 | 0.68 | 0.615-0.752 |
Thrombocytopenia | 9 (7.3) | 9 (15.8) | 0.078 | 2.375 | 0.888-6.351 |
Hyponatremia | 17 (13.8) | 9 (15.8) | 0.727 | 1.169 | 0.486-2.81 |
CSF study | Â | Â | Â | Â | Â |
Opening pressure (mmH2O) | 356.7 ± 143.6 | 379.9 ± 149.3 | 0.679 |  |  |
Sugar (mg/dl) | 40.77 ± 34.11 | 35.69 ± 27.80 | 0.390 |  |  |
Total Protein (mg/dl) | 210.30 ± 360.94 | 235.75 ± 339.47 | 0.688 |  |  |
Lactate (mg/dl) | 48.76 ± 34.90 | 65.38 ± 40.92 | 0.015 |  |  |
CSF cryptococcal antigen titer | Â | Â | Â | Â | Â |
≥1:1024 | 48 (39.0) | 41 (71.9) | <0.001 | 4.0 | 2.03-7.92 |
<1:1024 | 75 (61.0) | 16 (28.1) | Â | Â | Â |
Outcome | Â | Â | Â | Â | Â |
Median (IRQ) hospitalization days | 63.32 ± 49.39 | 48.44 ± 38.43 | 0.107 |  |  |